Clinical Trial Update: A Trial to Investigate the Safety of E303 in Participants With Advanced Refractory Solid Tumors [Phase 1]

View source ↗

Summary

This document reports an ongoing Phase 1 clinical trial to assess the safety of E303 in participants with advanced refractory solid tumors, sponsored by Samsung…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• E303

Snippet

Sponsor: Samsung Bioepis Co., Ltd. | Conditions: Advanced Solid Tumors | Phase 1 | Status: RECRUITING